Vericel Corp (VCEL) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-06

Key Insights

Insider Jonathan Hopper, the Chief Medical Officer, exercised 3,472 stock options at $10.95 and immediately sold the same number of shares at $35, indicating he is likely taking some profits.
Hopper still holds 75,556 shares directly, suggesting he maintains a substantial ownership stake in the company.
The transaction was executed pursuant to a pre-arranged 10b5-1 trading plan, indicating it was part of a systematic portfolio management strategy rather than an opportunistic sale.

Want the newest filings?

This analysis covers the filing from 2026-04-06. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-25

Heidi Hagen, a director of Vericel Corp, exercised 15,000 stock options at $2.76 per share and then immediately sold the underlying shares for $32.41 per share, indicating a significant profit on the transaction.
The sale was executed under a pre-arranged 10b5-1 trading plan, suggesting the transaction was part of a planned diversification or liquidity strategy rather than an opportunistic sale.
Hagen's remaining direct ownership of 31,850 shares represents a small fraction of Vericel's outstanding shares, indicating her stake is not a controlling or influential position.

Filed: 2026-02-13

The reporting person, Kevin McLaughlin, exercised 7,000 stock options with an exercise price of $2.63 per share, indicating their confidence in the company's future performance.
Following the exercise, the reporting person sold 7,000 shares at an average price of $34.66 per share, likely to diversify their portfolio or meet personal financial needs.
The reporting person still holds 15,100 shares of Vericel Corp (VCEL) directly, suggesting they maintain a substantial investment in the company.

Other reports for Vericel Corp

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.